BullyKamp
FDA warns that this pet company’s marketing bites off more than it can chew.
April 2015: After the parties agreed to voluntarily dismiss this lawsuit, a federal judge dismissed this lawsuit with prejudice (meaning that the plaintiffs cannot refile the complaint). The reasons for the dismissal have not yet been disclosed.
August 2014: Although a federal judge trimmed some of the claims in this class-action lawsuit (in response to the defendants’ motion to dismiss), the claims moving forward still allege that K9 Glucosamine does not work as advertised and does not contain the represented amount of chondroitin sulfate.
March 2014: A class-action lawsuit against Liquid Health Inc. was transferred from state court to federal court. The complaint, which was originally filed in state court in February 2014, alleges that the company deceptively represents that K9 Glucosamine (a dietary supplement for dogs) maintains the “health and resiliency of a dog’s joints and connective tissues” when the product actually does not work as advertised. In addition, plaintiffs claim that the company represents that each fluid ounce of the supplement contains 1,200 mg of chondroitin sulfate when, in reality, each fluid ounce only contains 16% of the promised concentration. (Hoffman et al v. Liquid Health Inc. and Alex Abreu, Case No. 14-cv-01838, D. NJ.).
For more information about other class-actions regarding products for dogs and TINA.org’s coverage of the topic, click here.
For more information about other class-action lawsuits regarding glucosamine and TINA.org’s coverage of the issue, click here.
FDA warns that this pet company’s marketing bites off more than it can chew.
TINA.org joins coalition of consumer organizations in support of the proposed rule
Company distances itself from touted “studies” while continuing to use deceptive health claims.
Can you earn a salary just by placing a small sticker on your car?
Lawsuits accuse companies of using deceptive claims to reel in consumers.